Navigation Links
Stem cells from umbilical cord used in the treatment of hepatic diseases
Date:7/3/2008

This release is available in Spanish.

Scientists of the University of Granada, in collaboration with the University of Len, have confirmed that stem cells from human umbilical cord blood can be an appropriate therapy for the treatment of hepatic diseases such as hepatitis, and therefore mean an effective alternative to bone marrow. According to a scientific paper which will be shortly published in the renowned journal Cell Transplantation, human umbilical cord blood cells (HUCBCs) can be useful for hepatic regenerative medicine, as they can nest in the liver after carrying out a human-to-rat xenotransplant.

This work, carried out by Ana I. lvarez-Mercado, Mara J. Sez-Lara, Mara V. Garca-Mediavilla, Sonia Snchez-Campos, Francisco Abada, Mara Cabello-Donayre, ngel Gil, Javier Gonzlez-Gallego and Luis Fontana, did research into the regenerative potential of HUCBCs cells using a xenotransplant model from human to rat in which HUCBCs were injected through the hepatic portal vein of rats with hepatitis caused by D-galactosamine.

Successfully in rats

The scientists explain that the cell transplant carried out in rats caused an improvement both in the histological damage and in the hepatic function, as proved by the enzymatic activities of alanine transaminase, alkaline phosphatase, gama-glutamyl-transpherase and lactate dehydrogenase, as well as the concentrations of total and direct bilirubin. The present treatment for terminal hepatic failure consists of a liver transplant. This method is, however, limited due to the lack of donor organs. In addition, there is not at present a specific treatment for the fibrosis caused by many hepatic diseases, so that receive a treatment for the complications of the disease. The development of such alternatives is therefore an essential objective for present research to improve suffering in many patients.


'/>"/>

Contact: Dr. Luis Fontana Gallego
fontana@ugr.es
34-958-242-335
Universidad de Granada
Source:Eurekalert

Related medicine news :

1. Circulating tumor cells can reveal genetic signature of dangerous lung cancers
2. Circulating Tumor Cells Reveal Insights Into Lung Cancers
3. Cancer cells revert to normal at specific signal threshold, Stanford researchers find
4. Laser surgery probe targets individual cancer cells
5. New Source of Heart Stem Cells Found
6. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
7. Star-Shaped Brain Cells Make Scans Possible
8. Patients own infection-fighting T cells put late-stage melanoma into long-term remission
9. New cancer treatment targets both tumor cells and blood vessels
10. Stem Cells Might Treat Tough Fractures
11. Penn researchers find key developmental pathway activates lung stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: